Apogenix Announces Oral and Poster Presentations at Upcoming International Conferences
HEIDELBERG, GERMANY / ACCESSWIRE / March 7, 2019 / Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today...